Long-Term Effects of COVID-19
Long-Term Effects of COVID-19 is a research topic within Neurology. Science Explorer counts 32k research works in it since 1951. 19.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the neurological manifestations and long-term effects of COVID-19 infection, including post-acute COVID-19 syndrome, neuroinvasion potential, neuropsychiatric presentations, and cognitive impairment. It explores the central nervous system involvement, respiratory failure, neuropathology, and chronic fatigue experienced by patients after acute COVID-19.
- Neurologic Manifestations
- Post-acute COVID-19 Syndrome
- Long COVID
- Neuropsychiatric Presentations
- Neuroinvasion Potential
- Respiratory Failure
- Central Nervous System Involvement
- Neuropathology
- Cognitive Impairment
- Chronic Fatigue
- Research works
- 32k fractional, since 1951
- In the world top 10%
- 6.2k per year above
- Top-10% rate
- 19.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +2587% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Long-Term Effects of COVID-19 research?
By volume, the United States and China publish the most (2.8k and 1k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.8k works
- 2 China 1k works
- 3 India 960 works
- 4 United Kingdom 793 works
- 5 Italy 792 works
- 6 Brazil 785 works
- 7 Germany 605 works
- 8 Russia 601 works
- 9 Spain 592 works
- 10 Türkiye 570 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Long-Term Effects of COVID-19 research?
By volume in 2022–2025, University of North Carolina at Chapel Hill publishes the most Long-Term Effects of COVID-19 research, followed by Sağlık Bilimleri Üniversitesi and All India Institute of Medical Sciences.
By volume, 2022–2025
- 1 University of North Carolina at Chapel HillUnited States 58 works
- 2 Sağlık Bilimleri ÜniversitesiTürkiye 55 works
- 3 All India Institute of Medical SciencesIndia 50 works
- 4 Tehran University of Medical SciencesIran 45 works
- 5 Universidade de São PauloBrazil 43 works
- 6 Harvard UniversityUnited States 40 works
- 7 University College LondonUnited Kingdom 39 works
- 8 Sechenov UniversityRussia 39 works
- 9 Shahid Beheshti University of Medical SciencesIran 36 works
- 10 Istituti di Ricovero e Cura a Carattere ScientificoItaly 36 works
Who are the leading researchers in Long-Term Effects of COVID-19?
The most-cited researchers publishing on Long-Term Effects of COVID-19 include Aziz Sheikh.
- 1 Aziz Sheikh United Kingdom 5.8k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Long-Term Effects of COVID-19 research done?
The largest centres of Long-Term Effects of COVID-19 research in 2022–2025 are London (United Kingdom), Moscow (Russia), Tehran (Iran) and Beijing (China).
Largest cities, 2022–2025
Where is the best place to study Long-Term Effects of COVID-19?
Among universities, judged by research, Victor Babeș University of Medicine and Pharmacy Timișoara, University College London and Karolinska Institutet score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Victor Babeș University of Medicine and Pharmacy TimișoaraRomania | 59.5 | 31.7% | 11.1× | 15 | — |
| 2 | University College LondonUnited Kingdom | 54.5 | 35.6% | 1.9× | 40 | +36.8% |
| 3 | Karolinska InstitutetSweden | 53.5 | 25.3% | 4.8× | 32 | +19.4% |
| 4 | Albert Einstein College of MedicineUnited States | 53.0 | 43.9% | 4.5× | 13 | — |
| 5 | Johns Hopkins UniversityUnited States | 52.7 | 29.6% | 2.2× | 35 | +100.0% |
| 6 | University of Hong KongHong Kong | 50.5 | 46.1% | 1.1× | 14 | — |
| 7 | Medical University of BiałystokPoland | 50.1 | 18.0% | 10.6× | 14 | — |
| 8 | Isfahan University of Medical SciencesIran | 49.6 | 8.8% | 8.2× | 28 | +76.1% |
| 9 | Harvard UniversityUnited States | 49.0 | 30.7% | 2.1× | 40 | +8.0% |
| 10 | University of OxfordUnited Kingdom | 48.2 | 37.3% | 1.2× | 24 | — |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Long-Term Effects of COVID-19 research growing?
Output in 2018–2022 was 2587% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Long-Term Effects of COVID-19.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.